Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News

A stent designed to dissolve after it completes its task of propping open narrowed heart arteries is being tested ...

Home October 24, 2006
Home
News

When it comes to opening blocked carotid arteries, surgery may be less risky than stents according to a study by ...

Home October 23, 2006
Home
News

Boston Scientific has European CE clearance to begin marketing a private-label XIENCE V everolimus-eluting coronary ...

Home October 17, 2006
Home
News

The new Fetch Aspiration Catheter from Possis Medical, Inc. has received 510(k) clearance from the FDA. Employing ...

Home October 17, 2006
Home
News

First U.S. installations of Volcano Corp.’s s5i IVUS (intravascular ultrasound) imaging system have been completed at ...

Home October 17, 2006
Home
News

An FDA-appointed advisory panel to review drug-eluting stents could have detrimental effects on the $6 billion-a-year ...

Home October 05, 2006
Home
Feature | Judy Hostert-Harvey

Having the most up-to-date blood gas readings is critical when dealing with many patients, especially pulmonary and ...

Home October 05, 2006
Home
News

Abbott Vascular says it will begin launching its XIENCE V stent system immediately in most European countries, focusing ...

Home October 04, 2006
Home
Case Study

The genesis of the Abaxis Piccolo technology began with NASA, where scientists sought to develop and manufacture a small ...

Home October 03, 2006
Home
News

Cordis Corp. has launched the CYPHER SELECT Plus Stent, the first third-generation DES, in Western and Eastern Europe ...

Home September 26, 2006
Home
Feature | Kim Phelan

Two of the six astronauts from the shuttle mission Atlantis became part of an ongoing cardiovascular study at NASA about ...

Home September 25, 2006
Home
News

Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent ...

Home September 18, 2006
Home
News

Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the ...

Home September 18, 2006
Home
News

GE Healthcare and Volcano Corp. have announced FDA 510(k) clearance for the integration of Volcano’s intravascular ...

Home September 18, 2006
Home
News

Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor

Cardiologists were urged to halt the ...

Home September 18, 2006
Home
Subscribe Now